Skip to content
value.today

Reimagine Care, Inc.

🇺🇸 Nashville, Tennessee, USAHealth CareFounded 2020
Total raised
$9 M
2 rounds on record
Latest round
$2 M
Nov 2025
First round on record
Jul 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Reimagine Care, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2025$2 MNo. 2$2 to $10 million

Reimagine Care, Inc.: Raise no. 2, Nov 2025

Investors in this round

7 investors had bought by the notice of Nov 19, 2025: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $7 M offered; $5 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Nardi · Executive Officer, Director · Mr. Nardi is the CEO and a director of the Issuer
  • Chris Stenzel · Director
  • Devin Carty · Director
  • Douglas French · Director
  • Feby Abraham · Director
  • Harlan Levine · Director
  • Keith Figlioli · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tyler Dove, By POA from Dan Nardi, CEO. Newest notice filed Nov 19, 2025. Read the notice at the SEC.

equitySEC
Jul 2021$6 MNo. 1$2 to $10 million

Reimagine Care, Inc.: Raise no. 1, Jul 2021

Investors in this round

9 investors had bought by the notice of Dec 3, 2021: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $25 M offered; $19 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron Gerber · Executive Officer, Director
  • Barbara Cannon · Executive Officer
  • Devin Carty · Director
  • Douglas French · Director
  • Keith Figlioli · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Aaron Gerber, President. Newest notice filed Dec 3, 2021 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Reimagine Care, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2025).

    SEC Form D · Nov 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Reimagine Care, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Reimagine Care, Inc.
NameRoleNamed in
Dan NardiMr. Nardi is the CEO and a director of the IssuerNov 2025
Aaron GerberExecutive officerDec 2021
Barbara CannonExecutive officerDec 2021
Chris StenzelDirectorNov 2025
Dan NardiMr. Nardi is the CEO and a director of the IssuerNov 2025
Devin CartyDirectorNov 2025
Douglas FrenchDirectorNov 2025
Feby AbrahamDirectorNov 2025
Harlan LevineDirectorNov 2025
Keith FiglioliDirectorNov 2025
Aaron GerberDirectorDec 2021